New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
10:51 EDTAPRIApricus Biosciences upgraded to Buy from Hold at Cantor
Cantor Fitzgerald upgraded Apricus Biosciences to Buy citing potential upcoming pipeline catalysts. The firm raised its price target for shares to $3 from $2.50.
News For APRI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 12, 2015
07:35 EDTAPRIApricus Biosciences appoints Catherine Bovenizer as Chief Accounting Officer
Apricus Biosciences announced the appointment of Catherine Bovenizer as the company's vice president of finance, Chief Accounting Officer. Bovenizer has been with companies in the biopharmaceutical industry, most recently holding the position of Executive Director and Controller with Ambit Biosciences.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use